Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
Google Backs Adimab, PVI Sweetens E Ink Deal, Sanofi-Aventis Partners With Merrimack Pharma, & More Boston-Area Deals News
|
Rebecca Zacks |
10/02/09 |
Boston
|
|
Genzyme Faces More Setbacks, Humedica Creating a Healthcare “Census,” Pops Back as Alkermes CEO, & More Boston-Area Life Science News
|
Ryan McBride |
09/30/09 |
Boston
|
|
Covidien to Buy Aspect Medical for $210M
|
Robert Buderi |
09/28/09 |
Boston
|
|
I-Therapeutix Raises $15M in Round Led by Polaris
|
Ryan McBride |
06/19/09 |
Boston
|
|
Link Makes $40M Connection, Concert and Indevus Launch Clinicals, Genzyme’s Big Cholesterol Strategy, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
10/01/08 |
Boston
|
|
Covidien Cuts Costs in All Four Business Units, Corporate
|
Luke Timmerman |
09/29/08 |
Boston
|
|
The “Augmenix” Question: Can Amar Sawhney Do It Again with Latest Hydrogel Startup?
|
Ryan McBride |
09/04/08 |
Boston
|
|
Corporate Life Sciences VCs on the Rise in New England—the List
|
Ryan McBride |
09/03/08 |
Boston
|
|
Dyax and Vertex Drugs Move Toward Market, Taligen Moves to MA, Covidien Moves Into Venture Territory, & More Life Sciences News
|
Rebecca Zacks |
08/20/08 |
Boston
|
|
Covidien Launches Venture Arm
|
Ryan McBride |
08/19/08 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
